High-precision dispensing with a syringe pump, high yield! Contributes to running costs!
The "Syro Series (I & II)" can synthesize a large number of peptides in a short time through automatic parallel operation. By minimizing flow paths, it reduces unnecessary consumption of amino acids and reagents, lowering running costs. Additionally, to prevent cross-contamination, each reaction vessel has an independent flow path. 【Features】 ■ More peptides can be synthesized through parallel synthesis ■ Heating up to 95°C is possible (optional) ■ Vortex stirring ■ High-precision dispensing with a syringe pump contributes to high yield and lower running costs *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
【Specifications】 ■Number of Samples Processed - Syro I: 24, 48, 96 samples - Syro II: Selectable reaction blocks of 48×2 or 96×3 ■Synthesis Scale - 24ch×10mL: 50–300μmol/sample - 24ch×5mL: 25–150μmol/sample - 48ch×2mL: 5–50μmol/sample - 96ch×0.7mL: 1–5μmol/sample *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■Peptide synthesis *For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
![[User Interview] PeptiDream Inc.](https://image.mono.ipros.com/public/catalog/image_generated/01/91e/414110/414110_IPROS6906907747746116559_1.jpg?w=120&h=170)
Company information
Biotage Japan Co., Ltd. is a wholly-owned subsidiary of Biotage AB, which is headquartered in Uppsala, Sweden (BIOT: NASDAQ/OMX Stockholm). Biotage AB has its roots in several venture companies that originated from Uppsala University, a leading science and engineering university in the Nordic region. After undergoing international acquisitions and restructuring throughout the 2000s, it has recently achieved remarkable growth as a global company.
